FDMT vs SHOP · rev $37.0K vs P/E 107, rev $11.56B
4D Molecular Therapeutics Inc (FDMT) versus Shopify Inc (SHOP) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Shopify Inc (SHOP) is a software - application company listed on US. It is led by Tobi Lutke.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported SHOP revenue for 2025-12-31 was $11.56B. Net income was $1.23B. Revenue was up 30.1% from 2024-12-31 to 2025-12-31. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
FDMT currently screens at market cap $518.1M. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
Not investment advice. Open the FDMT and SHOP stock pages for the full models.
Not investment advice.